Skip to main content

Point72 Asset Management, L.P.

Position in ENGN — enGene Therapeutics Inc.

CIK 1603466 STAMFORD, CT

Position in ENGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$24,206
-$1,156,586 QoQ
Shares Held
13,992
-91.9% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 60 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ENGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,264,515 across 171 Biotechnology names. ENGN ranks #164 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ENGN

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $24,206 13,992
2026-03-31 $1,180,792 173,391
2025-12-31 $5,073,026 561,797
2025-09-30 $8,253,365 1,208,399
2025-06-30 $4,398,208 1,208,299
2025-03-31 $5,560,522 1,241,188
2024-12-31 $8,144,900 1,224,797
2024-09-30 $4,375,800 663,000
2024-06-30 $413,977 43,900
2024-03-31 $3,094,832 182,586